Amdocs (NASDAQ:DOX) Releases Earnings Results, Beats Estimates By $0.01 EPS

Amdocs (NASDAQ:DOXGet Free Report) released its quarterly earnings data on Wednesday. The technology company reported $1.78 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.77 by $0.01, FiscalAI reports. The firm had revenue of $1.17 billion during the quarter, compared to analysts’ expectations of $1.17 billion. Amdocs had a return on equity of 20.19% and a net margin of 12.47%.The business’s revenue for the quarter was up 3.9% on a year-over-year basis. During the same quarter last year, the firm earned $1.78 earnings per share. Amdocs updated its FY 2026 guidance to 7.340-7.480 EPS and its Q3 2026 guidance to 1.810-1.870 EPS.

Here are the key takeaways from Amdocs’ conference call:

  • Amdocs reported a solid Q2 revenue of $1.17 billion and non-GAAP EPS of $1.78, both above the midpoint of guidance, with year-over-year growth in North America and record revenue in Europe.
  • The company secured several meaningful contract wins and extensions, including expanded managed services with Cricket Wireless, a 5-year CRM/OSS modernization deal with Vodafone Spain, and a multi-year charging system extension with KT.
  • Amdocs said its new aOS agentic operating system is getting early traction, with initial commercial agreements from Cricket, Lumen, Bell Canada, EchoStar, and PLDT; PLDT is already seeing over 90% of customer requests resolved through the platform.
  • Management reiterated full-year fiscal 2026 guidance, including 3% constant-currency revenue growth at the midpoint and roughly 6% non-GAAP EPS growth, while noting it is still monitoring customer spending amid macro uncertainty.
  • Cash generation remained strong, with $97 million in free cash flow before restructuring in Q2 and the company on track for $710 million to $730 million for fiscal 2026, supporting continued shareholder returns and liquidity.

Amdocs Stock Down 3.9%

Shares of NASDAQ:DOX traded down $2.41 on Wednesday, reaching $59.93. The company had a trading volume of 1,810,046 shares, compared to its average volume of 953,890. Amdocs has a twelve month low of $59.40 and a twelve month high of $95.41. The stock has a 50-day moving average price of $65.54 and a 200 day moving average price of $73.80. The stock has a market capitalization of $6.47 billion, a P/E ratio of 11.59, a P/E/G ratio of 1.10 and a beta of 0.40. The company has a quick ratio of 1.06, a current ratio of 1.06 and a debt-to-equity ratio of 0.23.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on DOX shares. Weiss Ratings reissued a “hold (c-)” rating on shares of Amdocs in a research report on Friday, May 8th. Stifel Nicolaus reduced their price objective on Amdocs from $97.00 to $88.00 and set a “buy” rating for the company in a research report on Wednesday, February 4th. Wall Street Zen raised Amdocs from a “hold” rating to a “buy” rating in a research report on Saturday, April 18th. Finally, Barclays reduced their price objective on Amdocs from $111.00 to $92.00 and set an “overweight” rating for the company in a research report on Wednesday, February 4th. Three equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $92.33.

Read Our Latest Report on DOX

Institutional Trading of Amdocs

A number of institutional investors and hedge funds have recently made changes to their positions in DOX. Amundi lifted its position in shares of Amdocs by 73.0% in the first quarter. Amundi now owns 13,778 shares of the technology company’s stock worth $1,217,000 after buying an additional 5,816 shares during the last quarter. Millennium Management LLC lifted its position in shares of Amdocs by 458.3% in the first quarter. Millennium Management LLC now owns 67,047 shares of the technology company’s stock worth $6,135,000 after buying an additional 55,038 shares during the last quarter. Goldman Sachs Group Inc. lifted its position in shares of Amdocs by 12.6% in the first quarter. Goldman Sachs Group Inc. now owns 331,146 shares of the technology company’s stock worth $30,300,000 after buying an additional 37,087 shares during the last quarter. Empowered Funds LLC lifted its position in shares of Amdocs by 12.0% in the first quarter. Empowered Funds LLC now owns 15,979 shares of the technology company’s stock worth $1,462,000 after buying an additional 1,709 shares during the last quarter. Finally, Jane Street Group LLC lifted its position in shares of Amdocs by 195.4% in the first quarter. Jane Street Group LLC now owns 115,929 shares of the technology company’s stock worth $10,608,000 after buying an additional 76,683 shares during the last quarter. Institutional investors and hedge funds own 92.02% of the company’s stock.

Amdocs News Summary

Here are the key news stories impacting Amdocs this week:

About Amdocs

(Get Free Report)

Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.

Read More

Earnings History for Amdocs (NASDAQ:DOX)

Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.